Company intelligence / Profile preview

ClearSky Medical Diagnostics

York, England, United Kingdom

Ownership: Private
Development stage: Other

Overview

ClearSky Medical Diagnostics has developed CE-marked, clinically validated, non-invasive intelligent medical devices such as PD-Monitor and LID-Monitor that objectively assess and monitor Parkinson’s disease diagnosis, progression, and levodopa-induced dyskinesia, and has deployed these devices in medical centers and clinical studies worldwide.[1][2][8]

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Partnerships

Shimmer Research / Verisense wearable sensor platform[6][8]Pharma trials involving exenatide in Parkinson's disease (clinical research support partnership)[6]

Beyond the preview

Go deeper on ClearSky Medical Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClearSky Medical Diagnostics.

Explore the full profile